🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
20 June 2015 | Analysis | By BioSpectrum Bureau
Top 20 APAC Country Analysis: Singapore
Singapore:
Singapore's bioscience industry has slowed down
Highlights
• Singapore collaborated with Korea to train and develop skilled talent in innovative medical technologies
• Medical technology giants in Singapore including Johnson & Johnson, Medtronics,
GE Healthcare and BD joined hands to form a medical technology industry platform to foster growth, innovation and policy development in medtech sector across Asia
• Troubled British drugmaker GlaxoSmithKline plans to establish new headquarters in Singapore to manage its Asia operations
• Singapore witnessed growth in medical technology manufacturing by 12.2 percent in the first month of 2015• Japan-based drug giant, Chugai pharmaceuticals to invest nearly $490 million in its research and development center in Singapore
• Singapore and GE Healthcare sealed a five-year technology research and development collaboration agreement with an investment of $20 million to co-develop the next generation of medical technologies
• Singapore launched Diagnostics Development hub to develop local diagnostic products with investment in clinicians, researchers, innovators and entrepreneurs